Skip to main content

Table 1 Timing of administration of IMP during mobilisation phase

From: Autologous stem cell transplantation in refractory Crohn’s disease – low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study

Day

1

2

3

4

5

6

7

8

9

10

11

12

Cyclophosphamide 1 g/m2

           

G-CSF (filgrastim) 5 μg/kg

    

   

Mesna (dose as per local practice)

           

PB CD34 count

       

Stem cell harvest

       

a

a

a

a

a

  1. aStem cell harvest is approximate, the day of this will depend on adequate CD34+ counts, as described above